CO4480033A1 - Proteina accesoria humana para receptores de la interleucina 1 - Google Patents
Proteina accesoria humana para receptores de la interleucina 1Info
- Publication number
- CO4480033A1 CO4480033A1 CO96002329A CO96002329A CO4480033A1 CO 4480033 A1 CO4480033 A1 CO 4480033A1 CO 96002329 A CO96002329 A CO 96002329A CO 96002329 A CO96002329 A CO 96002329A CO 4480033 A1 CO4480033 A1 CO 4480033A1
- Authority
- CO
- Colombia
- Prior art keywords
- accessory protein
- receptor
- antibody
- interleukin receptors
- human accessory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37626895A | 1995-01-23 | 1995-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4480033A1 true CO4480033A1 (es) | 1997-07-09 |
Family
ID=23484321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO96002329A CO4480033A1 (es) | 1995-01-23 | 1996-01-22 | Proteina accesoria humana para receptores de la interleucina 1 |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0808365A1 (ru) |
| JP (1) | JPH10512453A (ru) |
| AR (1) | AR003919A1 (ru) |
| AU (1) | AU4537096A (ru) |
| BR (1) | BR9606837A (ru) |
| CA (1) | CA2210724A1 (ru) |
| CO (1) | CO4480033A1 (ru) |
| CZ (1) | CZ208197A3 (ru) |
| EA (1) | EA199700265A1 (ru) |
| FI (1) | FI973089A0 (ru) |
| HU (1) | HUP9702458A2 (ru) |
| IL (1) | IL116796A0 (ru) |
| MX (1) | MX9705501A (ru) |
| NO (1) | NO973404D0 (ru) |
| PE (1) | PE64396A1 (ru) |
| PL (1) | PL321538A1 (ru) |
| TR (1) | TR199700652T1 (ru) |
| WO (1) | WO1996023067A1 (ru) |
| ZA (1) | ZA96333B (ru) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008969A1 (en) * | 1996-08-26 | 1998-03-05 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
| US6974682B1 (en) | 1996-08-26 | 2005-12-13 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
| ES2312179T3 (es) | 1996-12-06 | 2009-02-16 | Amgen Inc. | Terapia combinada que utiliza un inhibidor del il-1 para el tratamiento de enfermedades mediadas por el il-1. |
| US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| EP0979282A1 (en) | 1997-04-30 | 2000-02-16 | F. Hoffmann-La Roche Ag | Rat st38.2 chemokine |
| US6280955B1 (en) * | 1997-12-16 | 2001-08-28 | Tularik Inc. | Interleukin-1 receptor accessory proteins, nucleic acids and methods |
| CA2316034A1 (en) | 1997-12-23 | 1999-07-01 | Immunex Corporation | Sigirr dna and polypeptides |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| AU2002253842A1 (en) | 2000-10-31 | 2002-08-28 | Immunex Corporation | Il-1 receptor accessory protein |
| GB2375604A (en) * | 2001-05-18 | 2002-11-20 | Warner Lambert Co | Methods for screening using interleukin soluble trimolecular complex |
| TR201809008T4 (tr) | 2001-06-26 | 2018-07-23 | Amgen Fremont Inc | Opgl ye karşi antikorlar. |
| KR100453877B1 (ko) | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체 |
| AU2002324625B2 (en) * | 2001-08-07 | 2008-05-08 | Immunex Corporation | Interleukin-1 receptors in the treatment of diseases |
| DK1572946T3 (da) | 2002-09-06 | 2012-07-02 | Amgen Inc | Terapeutisk humant monoklonalt anti-IL-1R1-antistof |
| CA2557910C (en) | 2004-04-02 | 2012-05-29 | Amgen Inc. | Methods of reducing aggregation of il-1ra |
| US8618054B2 (en) | 2004-05-05 | 2013-12-31 | Valorisation-Rechereche Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| EP1751175B1 (en) * | 2004-05-05 | 2012-07-25 | VALORISATION-RECHERCHE, Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| JP2008542685A (ja) * | 2005-05-05 | 2008-11-27 | ヴァロリザーシヨン・アッシュエスジ，ソシエテ・アン・コマンディット | サイトカイン受容体修飾因子及びその使用 |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| TW200736277A (en) | 2005-11-14 | 2007-10-01 | Amgen Inc | RANKL antibody-PTH/PTHrP chimeric molecules |
| US20110044894A1 (en) | 2008-03-26 | 2011-02-24 | Cellerant Therapeutics, Inc. | Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof |
| EP2196476A1 (en) | 2008-12-10 | 2010-06-16 | Novartis Ag | Antibody formulation |
| GB2472856B (en) * | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| KR101989134B1 (ko) * | 2011-01-19 | 2019-06-13 | 칸타르기아 아베 | 항―ｉｌ１ｒａｐ 항체 및 그의 인간 치료 용도 |
| BR112013020220B1 (pt) | 2011-02-09 | 2020-03-17 | Natera, Inc. | Método para determinar o estado de ploidia de um cromossomo em um feto em gestação |
| CA2837651A1 (en) * | 2011-06-21 | 2012-12-27 | Oncofactor Corporation | Compositions and methods for the therapy and diagnosis of cancer |
| US8841418B2 (en) | 2011-07-01 | 2014-09-23 | Cellerant Therapeutics, Inc. | Antibodies that specifically bind to TIM3 |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| GB201403875D0 (en) | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| GB201413913D0 (en) | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
| EP4428863A2 (en) | 2015-05-11 | 2024-09-11 | Natera, Inc. | Methods and compositions for determining ploidy |
| CN108026172B (zh) | 2015-06-26 | 2022-04-29 | 赛诺菲生物技术公司 | 单克隆抗il-1racp抗体 |
| EP3241845A1 (en) | 2016-05-06 | 2017-11-08 | MAB Discovery GmbH | Humanized anti-il-1r3 antibodies |
| WO2018022982A1 (en) | 2016-07-29 | 2018-02-01 | Trustees Of Boston University | Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development |
| EP3401332A1 (en) | 2017-05-08 | 2018-11-14 | MAB Discovery GmbH | Anti-il-1r3 antibodies for use in inflammatory conditions |
| CA3067637A1 (en) | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free dna |
| WO2019118926A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
| EP3781714A1 (en) | 2018-04-14 | 2021-02-24 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna |
| TW202021618A (zh) | 2018-08-17 | 2020-06-16 | 美商２３與我有限公司 | 抗ｉｌ１ｒａｐ抗體及其使用方法 |
| US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
| WO2021236962A1 (en) | 2020-05-20 | 2021-11-25 | The Medical College Of Wisconsin, Inc. | Compositions and methods for inhibiting cytokine-release syndrome |
| CN114835799A (zh) * | 2021-05-28 | 2022-08-02 | 百奥赛图江苏基因生物技术有限公司 | Il1rap基因人源化非人动物的构建方法及应用 |
| WO2024062074A1 (en) | 2022-09-21 | 2024-03-28 | Sanofi Biotechnology | Humanized anti-il-1r3 antibody and methods of use |
-
1996
- 1996-01-15 PE PE1996000031A patent/PE64396A1/es not_active Application Discontinuation
- 1996-01-16 ZA ZA96333A patent/ZA96333B/xx unknown
- 1996-01-17 WO PCT/EP1996/000181 patent/WO1996023067A1/en not_active Application Discontinuation
- 1996-01-17 CZ CZ972081A patent/CZ208197A3/cs unknown
- 1996-01-17 IL IL11679696A patent/IL116796A0/xx unknown
- 1996-01-17 EA EA199700265A patent/EA199700265A1/ru unknown
- 1996-01-17 CA CA002210724A patent/CA2210724A1/en not_active Abandoned
- 1996-01-17 TR TR97/00652T patent/TR199700652T1/xx unknown
- 1996-01-17 PL PL96321538A patent/PL321538A1/xx unknown
- 1996-01-17 BR BR9606837A patent/BR9606837A/pt unknown
- 1996-01-17 JP JP8522598A patent/JPH10512453A/ja active Pending
- 1996-01-17 AU AU45370/96A patent/AU4537096A/en not_active Abandoned
- 1996-01-17 HU HU9702458A patent/HUP9702458A2/hu unknown
- 1996-01-17 MX MX9705501A patent/MX9705501A/es unknown
- 1996-01-17 EP EP96901291A patent/EP0808365A1/en not_active Withdrawn
- 1996-01-19 AR ARP960101095A patent/AR003919A1/es unknown
- 1996-01-22 CO CO96002329A patent/CO4480033A1/es unknown
-
1997
- 1997-07-22 FI FI973089A patent/FI973089A0/fi unknown
- 1997-07-23 NO NO973404A patent/NO973404D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO973404L (no) | 1997-07-23 |
| ZA96333B (en) | 1996-07-23 |
| AU4537096A (en) | 1996-08-14 |
| NO973404D0 (no) | 1997-07-23 |
| MX9705501A (es) | 1997-10-31 |
| EA199700265A1 (ru) | 1998-04-30 |
| PL321538A1 (en) | 1997-12-08 |
| EP0808365A1 (en) | 1997-11-26 |
| JPH10512453A (ja) | 1998-12-02 |
| CA2210724A1 (en) | 1996-08-01 |
| IL116796A0 (en) | 1996-05-14 |
| WO1996023067A1 (en) | 1996-08-01 |
| BR9606837A (pt) | 1998-05-26 |
| AR003919A1 (es) | 1998-09-30 |
| HUP9702458A2 (hu) | 1998-04-28 |
| CZ208197A3 (en) | 1997-11-12 |
| FI973089A (fi) | 1997-07-22 |
| FI973089A0 (fi) | 1997-07-22 |
| TR199700652T1 (xx) | 1998-02-21 |
| PE64396A1 (es) | 1997-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4480033A1 (es) | Proteina accesoria humana para receptores de la interleucina 1 | |
| ATE208820T1 (de) | Humanisierte antikoerper | |
| CY1106594T1 (el) | Αντισωματα εναντι ανθρωπινης il-12 | |
| BR0315123A (pt) | Composições farmacêuticas direcionadas a receptores erb-b1 | |
| MY154009A (en) | Anti-alpha v beta 6 antibodies | |
| DK0668924T3 (da) | Humaniserede antistoffer mod Fc-receptorer for immunoglobulin G på humane mononukleare fagocytter | |
| ATE178097T1 (de) | Monoklonale antikörper gegen den alpha-pdgf- rezeptor und deren verwendungen | |
| ATE391174T1 (de) | Modifizierter tpo-agonisten antikörper | |
| DK180380A (da) | Hybrid cellelinie og fremgangsmaade til fremstilling og anvendelse deraf | |
| CO5160384A1 (es) | Anticuerpo humanizado especifico para 4-1bb humano y composicion farmaceutica que comprende el mismo | |
| ITFI930246A1 (it) | Anticorpo monoclonale bispecifico anti-cd3/anti-egfr,processo per la produzione e suo uso. | |
| ES2152216T3 (es) | Usos terapeuticos de la region hipervariable del anticuerpo monoclonal m195 y constructos de la misma. | |
| ES2038571T1 (es) | Procedimiento de preparacion de anticuerpos monoclonales especificos de las interleucinas 1alfa y 1beta. | |
| ATE279443T1 (de) | A3c6e2, ein monoklonaler antikörper spezifisch für den humanen stammzellfaktor (scf)-rezeptor | |
| ES2110993T3 (es) | Anticuerpos monoclonales especificos para la toxina b de clostridium difficile. | |
| MX2022005949A (es) | Anticuerpos anti-ror-2 y metodos de uso. | |
| DK407987D0 (da) | Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer | |
| KR900701318A (ko) | 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체 | |
| ES2061769T3 (es) | Anticuerpo monoclonal y su utilizacion. | |
| ATE202117T1 (de) | Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma | |
| YU13392A (sh) | ANTITELA NA HUMANI RECEPTOR ZA IgE | |
| PT871612E (pt) | Isoindolonas fundidas como inibidores de proteina cinase c | |
| ES2053637T3 (es) | Anticuerpos monoclonales de sustancia que enlaza antitrombina y sus usos. | |
| DE59608073D1 (de) | Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid | |
| ATE215598T1 (de) | Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen |